3SOF

Hi !

Paradigm Medical Industries Completes Settlement of Federal and State Court Class Action Lawsuits
Sep 29, 2005 12:26:00 PM
Copyright Business Wire 2005
SALT LAKE CITY--(BUSINESS WIRE)--Sept. 29, 2005--

Paradigm Medical Industries, Inc. (OTCBB: PMED.OB/PMEDW.OB) today announced the completion of the settlement of the federal and state court class action lawsuits that were filed against the Company and its former executive officers, Thomas P. Motter, Mark M. Miehle, and John W. Hemmer.

On February 22, 2005, the Company executed written settlement agreements to settle the federal and state court class action lawsuits. As a condition to the settlement agreements, the courts in such lawsuits must have entered orders granting final approval of the settlements reached in those respective actions, and such orders must have become final and non-appealable.

On August 26, 2005, the federal court entered the order and final judgment granting final approval of the settlement agreement reached on February 22, 2005 in the federal court class action lawsuit, dismissing the complaint filed in the lawsuit with prejudice as against the Company and its former executive officers. In addition, the court permanently enjoined class members in the lawsuit and their successors and assigns from instituting any other actions against the Company and its former executive officers that had been or could have been asserted by the class members against the Company and its former executive officers in the federal court class action lawsuit.

Following the entry of the order and final judgment in the federal court class action lawsuit, there has been a 30-day period to appeal the order and final judgment. The 30-day period has now lapsed and no appeal was made of the order and final judgment. Consequently, the order and final judgment entered by the federal court is non-appealable.

Under the terms of settlement of the federal court class action lawsuit, U.S. Fire Insurance Company, which issued a Directors and Officers Liability and Company Reimbursement Policy to Paradigm Medical for the period from July 10, 2002 to July 10, 2003, agreed to pay the sum of $1,507,500 in cash to the class members that purchased securities of the Company during the period between April 17, 2002 and November 4, 2002.

On August 23, 2005, the state court entered a final judgment and order of dismissal with prejudice, granting final approval of the terms of settlement reached on February 23, 2005 in the state court class action lawsuit, dismissing the state class action lawsuit and all claims contained therein against the Company and its former executive officers, and enjoining the class members in the lawsuit from prosecuting the settled claims against the Company and its former executive officers.

Following the entry of the final judgment and order of dismissal with prejudice in the state court class action lawsuit, there has been a 30-day period to appeal the final judgment and order. The 30-day period has now lapsed and no appeal was made of the final judgment and order. Consequently, the final judgment and order entered by the state court is now non-appealable.

Under the terms of settlement of the state court class action lawsuit, U.S. Fire agreed to pay the sum of $625,000 in cash to the class members that purchased shares of Series E Convertible preferred stock on or about July 11, 2001.

Paradigm Medical Industries, Inc., currently develops, manufactures and markets surgical and diagnostic high-tech, proprietary equipment and consumable products for the medical industry. The Company's corporate offices are located at 2355 South 1070 West, Salt Lake City, Utah 84119. Call (801) 977-8970 or visit us at www.paradigm-medical.com.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events or outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

Source: Paradigm Medical Industries, Inc.



----------------------------------------------
Paradigm Medical Industries
Inc.
John Y. Yoon
CEO
801-977-8970



Good luck .
Evgeny.

Possible double bottom....Moving to the upside....
Volume is looking nice.Welcome back to penny land.

at least the alert came out during the lunchtime lull!! best time to make entries is now becaise everyone gets the news after 2 imo.IMO target of .06 to .09

Emerging Stock Report: Paradigm Looking Forward Again
10/11/05

Oct 11, 2005 (M2 PRESSWIRE via COMTEX) --
The Emerging Stock Report is following Paradigm Medical Industries, Inc. (OTCBB: PMED.OB/PMEDW.OB) up 57.3% today as it announced the completion of the settlement of the federal and state court class action lawsuits that were filed against the Company and its former executive officers, Thomas P. Motter, Mark M. Miehle, and John W. Hemmer.

Under the terms of settlement of the federal court class action lawsuit, U.S. Fire Insurance Company, which issued a Directors and Officers Liability and Company Reimbursement Policy to Paradigm Medical for the period from July 10, 2002 to July 10, 2003, agreed to pay the sum of $1,507,500 in cash to the class members that purchased securities of the Company during the period between April 17, 2002 and November 4, 2002. Under the terms of settlement of the state court class action lawsuit, U.S. Fire agreed to pay the sum of $625,000 in cash to the class members that purchased shares of Series E Convertible preferred stock on or about July 11, 2001.

Paradigm Medical Industries, Inc., currently develops, manufactures and markets surgical and diagnostic high-tech, proprietary equipment and consumable products for the medical industry. The company specializes in the development and marketing of diagnostic equipment for the ophthalmic market. These products include of topographers, autoperimeters and ultrasonic biomicroscopes and a unique Blood Flow Analyzer help the eye care professional's community diagnose and treat disorders of they eye such as glaucoma, cataracts and age-related macular degeneration. The Company's corporate offices are located in, Salt Lake City, Utah.

Recommended Guidelines for Eye Exams Before age 5:Toddlers should be screened for common childhood problems such as crossed eye, lazy eye, nearsightedness and farsightedness. From puberty to age 39 you should be checked if you experience any eye problems or visual changes such as pain, floaters, flashes of light, blurry vision, or eye injury. During ages 40 to 65 you should be examined every two to four years. Everyone over 65 should be examined every one to two years. People at higher risk for eye diseases need to be examined more often. For example, adults with diabetes should have yearly eye exams. Other people at higher risk include blacks over age 40, people with a family history of eye disease, or those with a history of eye injury.

Source: American Academy of Ophthalmology

Ian Birrell

The Emerging Stock Report profiles emerging growth companies and brings them to the attention of the investment community ahead of the market providing concise analysis and resources required in determining when a stock appears poised for growth.

Get a Complimentary Subscription at www.*********************** for your complimentary subscription.

Subscribers have access to investment research reports, tools for tracking and analyzing, current news, detailed company profiles and ESR "E-Alert" Services. ESR produces comprehensive, timely and dependable research available on the Internet.
_________________

Picked up a few shares.
What do you make of the retracement?
Still looking at .06 to .09?
Bob

Heres an updated chart of a possible G-pattern.

-fousc

gogogogogo

weird blocks today
especially the .04, could we see this soon?

MOMO ALERT


# of trades (50 days): pmed : 114 14 15 41 49 20 28 54 31 15 15 10 110 161 23 20 71 30 31 44 44 40 63 12 14 14 67 13 21 14 10 16 25 56 16 9 15 13 53 17 4 19 22 24 24 19 44 44 72 127

PMED.OB Average Volume:
3days: 5278808 +14.7%
10d: 4600600 +11.5%
30d: 4072472 +22.1%
90d: 3172358 +38.7%
180d: 1943644

2 gaps in a row now, today with retracement so hopefully another move up. when subs break .01 sometimes they do it hard and i hope so in this case with this type of volume increases.
already traded 8mill in first hour and a half today

PMED.OB Average Volume:
3days: 11335095 +76.8%
10d: 6412734 +27.0%
30d: 4684252 +27.8%
90d: 3382523 +39.4%
180d: 2051258

broke .009 from a few days ago to keep this trend reversal going. all this action lately without news, could get exciting if some positive developments come out from the company.

PMED.OB Average Volume:
3days: 7233423 -12.1%
10d: 8231779 +30.2%
30d: 5744571 +35.6%
90d: 3698850 +39.4%
180d: 2240890

# of trades (50 days) : pmed : 205 79 103 185 248 114 14 15 41 49 20 28 54 31 15 15 10 110 161 23 20 71 30 31 44 44 40 63 12 14 14 67 13 21 14 10 16 25 56 16 9 15 13 53 17 4 19 22 24 24

the increase in number of trades and volume recently coincides with the reversal of this stocks price. i expect an attempt at the 200 day moving average for the short term.

im in at .012
if we hit it like you think that will be well over a double for me
lets go!

added some more at these levels under a penny-
this retracement to .009 could be support around this level as .009 was the number we gapped up to last week

# of trades (50 days): pmed : 229 205 79 103 185 248 114 14 15 41 49 20 28 54 31 15 15 10 110 161 23 20 71 30 31 44 44 40 63 12 14 14 67 13 21 14 10 16 25 56 16 9 15 13 53 17 4 19 22 24
PMED.OB Average Volume:
3days: 8998575 +3.0%
10d: 8740566 +30.1%
30d: 6109615 +37.5%
90d: 3817464 +39.6%
180d: 2304046

just saw this from yesterday 
Feb 06, 2006 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold lists: Paradigm Medical Industries, Inc. ( PMED ), Rim Semiconductor Co. ( RSMI ), Pacific Gold Corp. ( PCFG ). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net/squeezetrigger.pdf.

Paradigm Medical Industries, Inc. ( PMED ) engages in the development and marketing of diagnostic equipment for the ophthalmic market. Its product families of topographers, autoperimeters, and ultrasonic biomicroscopes combined with its Blood Flow Analyzer help the eye care professionals community diagnose and treat disorders of the eye, such as glaucoma, cataracts, and age-related macular degeneration. Its products include LD400, a voice-based, affordable, computer autoperimeter capable of threshold, fast threshold, and suprathreshold testing; CT200E, a computer-based corneal topographer with output for contact lens fitting, as well as pre and post refractive surgical measurements; Ocular Blood Flow Analyzer, a tonometer designed to measure intraocular pressure and sensitive enough to detect pulsatile blood flow; P37 A-B Scan, an ultrasonic A and B Scan for biometry and imaging of the retina; P40, an ultrasonic biomicroscope; P45, an ultrasonic biomicroscope with A and B Scan capabilities in addition to 35 MHz; and P60, an ultrasonic biomicroscope with sulcus-to-sulcus imaging and self-contained water path probe. It markets its products through direct sales representatives, independent sales representatives, and ophthalmic product distributors in the United States, as well as internationally through a network of dealers. The company was founded by Thomas F. Motter and Robert W. Millar in 1989 and is headquartered in Salt Lake City, Utah. With 52.96 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of PMED.

hi
i added some today under a penny because of you mentioned support or some gaps. maybe doyer can you post another chart please?